Industry News
Award for Nulka Designer
Melbourne flight control systems specialist, Mal Crozier, from BAE Systems Australia has been officially recognised for his work in developing Nulka Missile Decoy system.
[ + ]GTG awarded further patents and forensic accreditation
Genetic Technologies' (ASX: GTG) non-coding DNA analysis and foetal cell separation patents have been allowed by the Canadian Patent Office -- almost 15 years after the company filed its first non-coding DNA patent. [ + ]
Ballard wins Clunies Ross award
South Australian biotechnologist Dr John Ballard has been awarded an ATSE Clunies Ross Award in recognition of his achievements in biochemical drug development over the course of his career, which has included starting three biotechnology companies, and more recently an investment organisation, BioAngels. [ + ]
Bionomics files patent on angiogenesis gene trove
Adelaide-based meditech Bionomics LIMITED (ASX:BNO, US OTC:BMICY) has filed another international patent application on 496 potential gene targets for angiogenesis-inhibiting drugs. [ + ]
A life of Turbulence Rewarded
The University of Newcastle's Professor Robert Antonia, from the Faculty of Engineering and Built Environment, is considered a leading authority on turbulence.
[ + ]China OKs Brazil GMO soybean imports
China approved the importation of genetically modified soybeans from Brazil, which should allow shipments to begin as early as Tuesday for the world's largest soybean importer, according to Brazil's Agriculture Ministry. [ + ]
Virax raises $3.7 million in placement
Virax (ASX: VHL) announced this week that it had raised AUD$3.7 million through a placement to institutional and professional investors. [ + ]
Cogstate licences angiotensin compounds for Alzheimers
Recently listed company CogState (ASX: CGS) has signed a licensing and research collaboration deal with Pacific Northwest Biotechnology (PNB) in the US to develop a drug to treat Alzheimer's disease. [ + ]
Benitec defends patents
Brisbane-based biotech Benitec Limited (ASX: BLT) has fired the first shot in what may become a major international battle to determine ownership of key patents to RNA interference (RNAi), which has been described as the most powerful tool for gene technology since the invention of the polymerase chain reaction (PCR) two decades ago. [ + ]
Allergan files INDs for Peplin's topical treatment
Peplin Biotech (ASX: PEP) today announced the filing of three separate Investigational New Drug (IND) applications with the US Food and Drug Administration for a topical formulation of its lead compound PEP005. [ + ]
Select Vaccines signs agreement to develop Hep C test
Select Vaccines (ASX: SLT) has signed a materials transfer agreement (MTA) with a multinational biotechnology company to access materials it will use to accelerate the development of its hepatitis C rapid diagnostic test. [ + ]
Prana appoints US analyst to board
Melbourne biotech company Prana Biotechnology (ASX: PBT) has appointed leading US biotech analyst Dr Jonas Alsenas to its board of directors. [ + ]
Bracks bans GMHT canola until 2008
The Victorian Government has announced a four-year, legislated moratorium on commercial cropping of genetically modified herbicide-tolerant (GMHT) canola. [ + ]
DSTO and Adelaide Uni 'sign up' for future research
The Defence Science and Technology Organisation (DSTO) and the University of Adelaide have extended their research collaboration with the signing of a Strategic Alliance which recognises existing research links and creates a framework for increased cooperation in the future.
[ + ]Biota signs new flu diagnostic agreement
Biota (ASX:BTA) has signed a new agreement with its US-based flu diagnostics partner Thermo Electron giving it a profit share in a second influenza diagnostic kit, FLU OIA A/B. [ + ]